Clinical Trial Update: Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial updating safety and efficacy of UC-MSCs (umbilical cord-derived mesenchymal stem cells) in patients with moderate to severe plaque psoria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• UC-MSCs (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Tianjin Ever Union Biotechnology Co., Ltd. | Conditions: Moderate and Severe Plaque Psoriasis | Phase 1 | Status: UNKNOWN